Andy Fuller Appointed VP of Market Access at AESAR

AESARA, a leading digital-forward Value & Access agency, is pleased to announce the appointment of Andy Fuller as Vice President of US Market Access within its Strategic Partnerships team. With over 27 years of experience in the pharmaceutical industry, Andy Fuller brings extensive expertise in developing and executing go-to-market and payer engagement strategies across highly competitive markets.

Ruslan Horblyuk, Chief Strategic Consulting Officer at AESARA, commented, “Andy’s impressive track record in Sales, Marketing, and Market Access leadership roles makes him an ideal addition to our Strategic Partnerships team. His expertise aligns perfectly with our focus on expanding AESARA’s Value and Access portfolio and capabilities. We’re excited to work alongside Andy and benefit from his wealth of experience.”

Fuller’s appointment comes at a pivotal time for AESARA as the company continues to deliver innovative and trusted solutions that drive transformative market access for its clients.

“I’m thrilled to join AESARA and contribute to its mission of powering transformative market access,” said Andy Fuller. “The pharmaceutical landscape is rapidly evolving, and I look forward to leveraging my experience to help our clients navigate these changes and maximize their market impact.”

Sissi Pham, CEO of AESARA, added, “We are delighted to welcome Andy Fuller to our Value & Access team. His extensive industry knowledge and strategic insights will be invaluable as we continue to elevate our clients’ market access influence within their organizations and the decisionmakers within the US healthcare ecosystem. With Fuller’s addition, AESARA reinforces its commitment to providing cutting-edge market access solutions and further solidifies its position as a leader in the Value & Access space.”

SourceAESARA

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.